Status
Conditions
Treatments
About
A post market, prospective, non-randomized, multi-center, open-label, clinical study using survivorship as the reference performance goal to study the safety and efficacy of the Titan Modular Shoulder System 2.5 when used for primary shoulder arthroplasty.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For total shoulder arthroplasty, subjects must meet a, b, or c below:
For shoulder hemiarthroplasty, subjects must meet any of the sub-criteria a - g below:
Exclusion criteria
58 participants in 1 patient group
Loading...
Central trial contact
Derick Bermudez
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal